Guideline recommendations for earlier initiation of biologics in children and adults with Crohn’s disease are not always heeded in clinical practice, which may be detrimental to patient outcomes, according to studies presented at the 2022 annual meeting of the American College of Gastroenterology and 2023 Crohn’s & Colitis Congress.
Using Military Health System data, one group of investigators found decreased complications among patients who started biologics within two years of